NASDAQ: CLSD
Clearside Biomedical Inc Stock Ownership - Who owns Clearside Biomedical?

Insider buying vs selling

Have Clearside Biomedical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Clay ThorpDirector2025-02-2415,000$0.92
$13.80kBuy
Ngai Hang Victor ChongChief Medical Officer2024-11-0136,500$1.00
$36.50kBuy

1 of 1

CLSD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLSD insiders and whales buy or sell their stock.

CLSD Shareholders

What type of owners hold Clearside Biomedical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Clay Thorp9.21%7,154,702$5.93MInsider
Bradford T. Whitmore8.81%6,845,186$5.67MInsider
Hatteras Venture Advisors IV Sbic LLC5.34%4,150,684$3.44MInsider
Hatteras Venture Advisors III LLC4.56%3,540,739$2.94MInsider
Vanguard Group Inc3.61%2,806,607$2.33MInstitution
Cormorant Asset Management LP2.56%1,988,208$1.65MInsider
Rmi Investments Sarl2.00%1,558,024$1.29MInsider
Carmignac Gestion1.94%1,508,342$1.25MInstitution
Blackrock Inc1.03%800,920$663.96kInstitution
Geode Capital Management LLC1.02%792,247$656.77kInstitution

1 of 3

CLSD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLSD11.34%35.27%Net Buying
ANEB41.32%58.68%Net Buying
STRO73.02%18.21%Net SellingNet Selling
ACET67.53%19.44%Net Selling
VTGN36.56%63.44%Net BuyingNet Buying

Clearside Biomedical Stock Ownership FAQ

Who owns Clearside Biomedical?

Clearside Biomedical (NASDAQ: CLSD) is owned by 11.34% institutional shareholders, 35.27% Clearside Biomedical insiders, and 53.39% retail investors. Clay Thorp is the largest individual Clearside Biomedical shareholder, owning 7.15M shares representing 9.21% of the company. Clay Thorp's Clearside Biomedical shares are currently valued at $5.92M.

If you're new to stock investing, here's how to buy Clearside Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.